Thomas Dresing, M.D.
NPI 1770513640 · Cardiovascular Disease Physician · Cleveland, OH
Enrolled with Medicare as Practitioner - Cardiac Electrophysiology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1770513640
- Entity type
- Individual
- Primary specialty
- Cardiovascular Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 35080844 (OH)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
442 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Evaluation of Single, Dual, Multiple Lead Or Leadless Pacemaker System, Remote Up to 90 Days93294 | 128 | $28 |
| Evaluation of Cardiac Rhythm Monitor System, Remote Up to 30 Days93298 | 62 | $29 |
| Evaluation of Single, Dual, Or Multiple Lead Implantable Defibrillator System, Remote Up to 90 Days93295 | 60 | $34 |
| Heart Rhythm Review and Interpretation of Continous External Ekg Over 8-15 Days93248 | 59 | $24 |
| Programming of Dual Lead Pacemaker System93280 | 37 | $34 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 25 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 28 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Apixabanbrand: Eliquis | 429 | 123 |
| Metoprolol Succinate | 228 | 83 |
| Dofetilide | 173 | 59 |
| Rivaroxabanbrand: Xarelto | 162 | 38 |
| Flecainide Acetate | 83 | 32 |
| Amiodarone Hcl | 71 | 25 |
| Warfarin Sodium | 53 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$319 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-04
- Last updated
- 2008-01-30
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.